135 related articles for article (PubMed ID: 17012847)
1. Sucrose breath testing and intestinal mucositis.
Keefe DM; Gibson RJ
Cancer Biol Ther; 2006 Sep; 5(9):1196-8. PubMed ID: 17012847
[No Abstract] [Full Text] [Related]
2. A non-invasive method for detection of intestinal mucositis induced by different classes of chemotherapy drugs in the rat.
Howarth GS; Tooley KL; Davidson GP; Butler RN
Cancer Biol Ther; 2006 Sep; 5(9):1189-95. PubMed ID: 16931906
[TBL] [Abstract][Full Text] [Related]
3. Use of the 13C-sucrose breath test to assess chemotherapy-induced small intestinal mucositis in the rat.
Clarke JM; Pelton NC; Bajka BH; Howarth GS; Read LC; Butler RN
Cancer Biol Ther; 2006 Jan; 5(1):34-8. PubMed ID: 16294027
[TBL] [Abstract][Full Text] [Related]
4. A novel non-invasive biomarker for assessment of small intestinal mucositis in children with cancer undergoing chemotherapy.
Tooley KL; Saxon BR; Webster J; Zacharakis B; McNeil Y; Davidson GP; Butler RN
Cancer Biol Ther; 2006 Oct; 5(10):1275-81. PubMed ID: 17012839
[TBL] [Abstract][Full Text] [Related]
5. Optimization of the non-invasive 13C-sucrose breath test in a rat model of methotrexate-induced mucositis.
Tooley KL; Howarth GS; Lymn KA; Butler RN
Cancer Chemother Pharmacol; 2010 Apr; 65(5):913-21. PubMed ID: 19690860
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers of small intestinal mucosal damage induced by chemotherapy: an emerging role for the 13C sucrose breath test.
Wardill HR; Bowen JM; Gibson RJ
J Support Oncol; 2013 Jun; 11(2):61-7. PubMed ID: 23158908
[TBL] [Abstract][Full Text] [Related]
7. Lyprinol only partially improves indicators of small intestinal integrity in a rat model of 5-fluorouracil-induced mucositis.
Torres DM; Tooley KL; Butler RN; Smith CL; Geier MS; Howarth GS
Cancer Biol Ther; 2008 Feb; 7(2):295-302. PubMed ID: 18059190
[TBL] [Abstract][Full Text] [Related]
8. Non-invasive detection of a palifermin-mediated adaptive response following chemotherapy-induced damage to the distal small intestine of rats.
Yazbeck R; Howarth GS; Borges L; Geier MS; Smith CL; Davidson GP; Butler RN
Cancer Biol Ther; 2011 Sep; 12(5):399-406. PubMed ID: 21705855
[TBL] [Abstract][Full Text] [Related]
9. In a methotrexate-induced model of intestinal mucositis, olmesartan reduced inflammation and induced enteropathy characterized by severe diarrhea, weight loss, and reduced sucrose activity.
de Araújo AA; Borba PB; de Souza FH; Nogueira AC; Saldanha TS; Araújo TE; da Silva AI; de Araújo Júnior RF
Biol Pharm Bull; 2015; 38(5):746-52. PubMed ID: 25947920
[TBL] [Abstract][Full Text] [Related]
10. Mucositis and non-invasive markers of small intestinal function.
Tooley KL; Howarth GS; Butler RN
Cancer Biol Ther; 2009 May; 8(9):753-8. PubMed ID: 19276675
[TBL] [Abstract][Full Text] [Related]
11. The significance of altered gastrointestinal permeability in cancer patients.
Melichar B; Zezulová M
Curr Opin Support Palliat Care; 2011 Mar; 5(1):47-54. PubMed ID: 21326003
[TBL] [Abstract][Full Text] [Related]
12. Oropharyngeal mucositis-specific quality-of-life measure in patients with cancer therapy.
Cheng KK; Leung SF; Liang RH; Tai JW; Yeung RM; Thompson DR
Hong Kong Med J; 2010 Jun; 16 Suppl 3():42-6. PubMed ID: 20601734
[No Abstract] [Full Text] [Related]
13. A novel breath test for the non-invasive assessment of small intestinal mucosal injury following methotrexate administration in the rat.
Pelton NS; Tivey DR; Howarth GS; Davidson GP; Butler RN
Scand J Gastroenterol; 2004 Oct; 39(10):1015-6. PubMed ID: 15513344
[No Abstract] [Full Text] [Related]
14. Management of oral and gastrointestinal mucositis: ESMO clinical recommendations.
Peterson DE; Bensadoun RJ; Roila F;
Ann Oncol; 2009 May; 20 Suppl 4():174-7. PubMed ID: 19454447
[No Abstract] [Full Text] [Related]
15. Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis.
Billeschou A; Hunt J; Kissow H
J Vis Exp; 2019 May; (147):. PubMed ID: 31132057
[TBL] [Abstract][Full Text] [Related]
16. Complementary medicines: emerging therapies for intestinal mucositis.
Yazbeck R; Howarth GS
Cancer Biol Ther; 2009 Sep; 8(17):1629-31. PubMed ID: 19633432
[No Abstract] [Full Text] [Related]
17. Oral ingestion of Streptococcus thermophilus does not affect mucositis severity or tumor progression in the tumor-bearing rat.
Tooley KL; Howarth GS; Lymn KA; Lawrence A; Butler RN
Cancer Biol Ther; 2011 Jul; 12(2):131-8. PubMed ID: 21508671
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy-induced modifications to gastrointestinal microflora: evidence and implications of change.
Stringer AM; Gibson RJ; Bowen JM; Keefe DM
Curr Drug Metab; 2009 Jan; 10(1):79-83. PubMed ID: 19149515
[TBL] [Abstract][Full Text] [Related]
19. Detecting gut injury during chemotherapy: is a breath test the answer?
Wardill HR; Gibson RJ
Future Oncol; 2013 Sep; 9(9):1245-7. PubMed ID: 23692047
[No Abstract] [Full Text] [Related]
20. Oral ingestion of streptococcus thermophilus diminishes severity of small intestinal mucositis in methotrexate treated rats.
Tooley KL; Howarth GS; Lymn KA; Lawrence A; Butler RN
Cancer Biol Ther; 2006 Jun; 5(6):593-600. PubMed ID: 16627985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
